1 – 10 of 66
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Safety and Tolerability of SGLT2 Inhibitors in Cardiac Amyloidosis—A Clinical Feasibility Study
(
- Contribution to journal › Article
-
Mark
Bone mineral density after exercise training in patients with chronic kidney disease stages 3 to 5 : a sub-study of RENEXC—a randomized controlled trial
(
- Contribution to journal › Article
-
Mark
Performance of the European Kidney Function Consortium (EKFC) creatinine-based equation in United States cohorts
(
- Contribution to journal › Article
-
Mark
CVOT Summit Report 2023 : new cardiovascular, kidney, and metabolic outcomes
(
- Contribution to journal › Debate/Note/Editorial
- 2023
-
Mark
Renoprotective effects of genetically proxied fibroblast growth factor 21 : Mendelian randomization, proteome-wide and metabolome-wide association study
(
- Contribution to journal › Article
-
Mark
Statin Treatment Intensity, Discontinuation, and Long-Term Outcome in Patients with Acute Myocardial Infarction and Impaired Kidney Function
(
- Contribution to journal › Article
-
Mark
Coronary artery calcification and aortic valve calcification in patients with kidney failure : a sex-disaggregated study
(
- Contribution to journal › Article
-
Mark
The Borg scale is a sustainable method for prescribing and monitoring self-administered aerobic endurance exercise in patients with chronic kidney disease
(
- Contribution to journal › Article
-
Mark
Kidney outcomes in early adolescence following perinatal asphyxia and hypothermia-treated hypoxic-ischaemic encephalopathy
(
- Contribution to journal › Article
-
Mark
Elevated circulating follistatin associates with increased risk of mortality and cardiometabolic disorders
2023) In Nutrition, Metabolism and Cardiovascular Diseases(
- Contribution to journal › Article